Anúncio
Anúncio
SER
Serina Therapeutics, Inc.
2.50
USDPatrocinado
-0.12
-4.58%
09 de jan., 15:59 UTC -5
Encerrado
Pós-Mercado
2.43
-0.07
-2.80%
Relatórios de Lucros SER
Rácio de surpresa positiva
SER separação 2 de 3 últimas estimativas.
67%
Próximo Relatório
Data do Próximo Relatório
23 de mar. de 2026
Estimate for Q4 26 (Revenue/ EPS)
--
/-$0.44
Mudanças implicadas de Q3 25 (Revenue/ EPS)
--
/-13.73%
Mudanças implicadas de Q4 25 (Revenue/ EPS)
--
/--
Serina Therapeutics, Inc. earnings per share and revenue
On 13 de nov. de 2025, SER reported earnings of -0.51 USD per share (EPS) for Q3 25, beating the estimate of -0.53 USD, resulting in a 4.73% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -2.49% price change (close before vs. close after earnings).
Looking ahead to Q4 26, 3 analistas forecast an EPS of -0.44 USD, with revenue projected to reach -- USD, implying an diminuir of -13.73% EPS, and aumentar of 0.00% in Revenue from the last quarter.
FAQ
What were Serina Therapeutics, Inc.'s earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Serina Therapeutics, Inc. reported EPS of -$0.51, beating estimates by 4.73%, and revenue of $0.00, 0% as expectations.
How did the market react to Serina Therapeutics, Inc.'s Q3 2025 earnings?
The stock price moved down -2.49%, changed from $4.02 before the earnings release to $3.92 the day after.
When is Serina Therapeutics, Inc. expected to report next?
The next earning report is scheduled for 23 de mar. de 2026.
What are the forecasts for Serina Therapeutics, Inc.'s next earnings report?
Based on 3
analistas, Serina Therapeutics, Inc. is expected to report EPS of -$0.44 and revenue of -- for Q4 2026.
Which companies are reporting earnings today?
Verificar FXEmpire's Earnings Calendar for today's list of reporting companies.
Anúncio